Edition:
United States

Miraca Holdings Inc (4544.T)

4544.T on Tokyo Stock Exchange

5,120JPY
22 Sep 2017
Change (% chg)

¥20 (+0.39%)
Prev Close
¥5,100
Open
¥5,150
Day's High
¥5,150
Day's Low
¥5,080
Volume
145,200
Avg. Vol
225,511
52-wk High
¥5,570
52-wk Low
¥4,430

Latest Key Developments (Source: Significant Developments)

Avista Capital Partners to acquire Miraca Life Sciences
7:00am EDT 

Sept 22 (Reuters) - Avista Capital Ii [RIC:RIC:AVAAA.UL]:Avista Capital Partners says ‍Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc​.  Full Article

Miraca Holdings says change of unit
5:28am EDT 

Sept 22 (Reuters) - Miraca Holdings Inc <4544.T>:Says co's unit Miraca Life Sciences Inc's parent company CDx Holdings Inc (CDx) will merge with Avista Capital Holdings LP's unit Symphony Merger Sub Inc (Merger Sub) to become one company (CDx & Merger Sub).Says co will hold 15 percent stake in new holding company Symphony Buyer Inc, which will indirectly hold 100 percent in CDx & Merger Sub.Says co will cut all stake in unit Miraca Life Sciences Inc after the merger in November .Says transaction amount is $175.6 million .  Full Article

‍Morphotek announces agreement with Fujirebio Diagnostics to commercialize CA125 II assay as companion diagnostic for Farletuzumab​
Tuesday, 5 Sep 2017 10:00am EDT 

Sept 5 (Reuters) - Morphotek::Announces agreement with Fujirebio Diagnostics, Inc. to commercialize CA125 II assay as a companion diagnostic for Farletuzumab​.Agreement provides Fujirebio with worldwide license to develop, manufacture and commercialize CA125 II assay as a companion diagnostic​.  Full Article

Miraca Holdings says business transfer between two units
Thursday, 11 May 2017 03:01am EDT 

May 11(Reuters) - Miraca Holdings Inc <4544.T>:Says a Tokyo-based wholly owned unit FRHD will take over the subsidiary management business from its unit FUJIREBIO Inc., on July 1 .  Full Article

R&I affirms Miraca Holdings's rating at "A" and says stable outlook-R&I
Monday, 17 Apr 2017 04:40am EDT 

April 17 (Reuters) - Miraca Holdings Inc <4544.T>:* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I.* Rating outlook stable-R&I.  Full Article

R&I affirms Miraca Holdings Inc‘s rating at "A" and stable outlook
Wednesday, 27 Apr 2016 02:00am EDT 

Miraca Holdings Inc:Rating and Investment Information, Inc. (R&I) affirmed the rating on Miraca Holdings at "A".Rating outlook stable.  Full Article

Miraca Holdings revises consolidated full-year outlook for FY 2016; announces year-end dividend forecast not changed for FY 2016
Wednesday, 27 Jan 2016 01:15am EST 

Miraca Holdings Inc:Says the company remained the consolidated full-year outlook for revenue at 210,000 million yen for FY ending March 2016.Operating profit forecast remained at 25,700 million yen.Ordinary profit forecast remained at 24,500 million yen.Net profit forecast decreased to -5,800 million yen from 14,900 million yen.Earnings per share decreased to -101.8 yen from 261.59 yen.Comments the extraordinary loss is the main reason for the forecast.Says year-end dividend forecast not changed for FY ending March 2016.  Full Article

Miraca Holdings revises consolidated full-year outlook for FY 2016
Friday, 30 Oct 2015 02:15am EDT 

Miraca Holdings Inc:Says the company remained the consolidated full-year outlook for revenue at 210,000 million yen for FY ending March 2016.Sees a decrease of operating profit forecast to 25,700 million yen from 27,700 million yen.Sees a decrease of ordinary profit forecast to 24,500 million yen from 26,950 million yen.Sees a decrease of net profit forecast to 14,900 million yen from 16,900 million yen.Sees a decrease of earnings per share to 261.59 yen from 296.80 yen.Comments the lower-than-expected volume of business is the main reason for the forecast.  Full Article

BRIEF-Avista Capital Partners to acquire Miraca Life Sciences

* Avista Capital Partners says ‍Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc​ Source text for Eikon: Further company coverage: